Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLURAZEPAM for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where FLURAZEPAM was used for Chronic hepatitis c.

Most Reported Side Effects for FLURAZEPAM

Side Effect Reports % Deaths Hosp.
Drug abuse 304 31.2% 7 217
Sopor 207 21.2% 0 157
Intentional self-injury 158 16.2% 0 98
Toxicity to various agents 145 14.9% 43 91
Suicide attempt 132 13.5% 0 94
Intentional overdose 122 12.5% 5 73
Drug ineffective 84 8.6% 0 48
Hypotension 79 8.1% 1 55
Coma 70 7.2% 4 49
Confusional state 70 7.2% 6 59
Somnolence 66 6.8% 2 37
Overdose 53 5.4% 12 34
Bradyphrenia 47 4.8% 0 36
Insomnia 46 4.7% 2 22
Intentional product misuse 43 4.4% 1 23

Other Indications for FLURAZEPAM

Product used for unknown indication (450) Insomnia (108) Drug abuse (57) Intentional self-injury (47) Depression (23) Anxiety (21) Sleep disorder (21) Suicide attempt (20) Schizophrenia (17) Personality disorder (15)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

FLURAZEPAM Full Profile All Chronic hepatitis c Drugs FLURAZEPAM Demographics FLURAZEPAM Timeline